193 related articles for article (PubMed ID: 6443014)
1. A rapid method for testing in vivo the susceptibility of different strains of Trypanosoma cruzi to active chemotherapeutic agents.
Filardi LS; Brener Z
Mem Inst Oswaldo Cruz; 1984; 79(2):221-5. PubMed ID: 6443014
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas disease.
Filardi LS; Brener Z
Trans R Soc Trop Med Hyg; 1987; 81(5):755-9. PubMed ID: 3130683
[TBL] [Abstract][Full Text] [Related]
3. Effects of trypanocidal drugs on protein biosynthesis in vitro and in vivo by Trypanosoma cruzi.
Gonzalez NS; Cazzulo JJ
Biochem Pharmacol; 1989 Sep; 38(17):2873-7. PubMed ID: 2673249
[TBL] [Abstract][Full Text] [Related]
4. Damage of Trypanosoma cruzi deoxyribonucleic acid by nitroheterocyclic drugs.
Goijman SG; Frasch AC; Stoppani AO
Biochem Pharmacol; 1985 May; 34(9):1457-61. PubMed ID: 3888226
[TBL] [Abstract][Full Text] [Related]
5. Role of glutathione in the susceptibility of Trypanosoma cruzi to drugs.
Moncada C; Repetto Y; Aldunate J; Letelier ME; Morello A
Comp Biochem Physiol C Comp Pharmacol Toxicol; 1989; 94(1):87-91. PubMed ID: 2576749
[TBL] [Abstract][Full Text] [Related]
6. [Different effects of nifurtimox and benznidazole on the biosynthesis of DNA, RNA and proteins in Trypanosoma cruzi].
Goijman SG; Frasch AC; Stoppani AO
Medicina (B Aires); 1984; 44(3):261-70. PubMed ID: 6085847
[No Abstract] [Full Text] [Related]
7. [Treatment of Chagas' disease].
Apt W
Rev Med Chil; 1985 Feb; 113(2):162-6. PubMed ID: 3936147
[No Abstract] [Full Text] [Related]
8. Trypanocidal activity of 4 isopropyl salicylaldehyde and 4-isopropyl salicylic acid on Trypanosoma cruzi.
Nogueda-Torres B; Rodríguez-Paez L; Ramírez IB; Ramírez CW
Rev Latinoam Microbiol; 2001; 43(1):1-6. PubMed ID: 17061565
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo trypanocidal activity of the ethyl esters of N-allyl and N-propyl oxamates using different Trypanosoma cruzi strains.
Aguirre-Alvarado C; Zaragoza-Martínez F; Rodríguez-Páez L; Nogueda B; Baeza I; Wong C
J Enzyme Inhib Med Chem; 2007 Apr; 22(2):227-33. PubMed ID: 17518350
[TBL] [Abstract][Full Text] [Related]
10. Trypanocidal effect of the benzyl ester of N-propyl oxamate: a bi-potential prodrug for the treatment of experimental Chagas disease.
Wong-Baeza C; Nogueda-Torres B; Serna M; Meza-Toledo S; Baeza I; Wong C
BMC Pharmacol Toxicol; 2015 Apr; 16():10. PubMed ID: 25896924
[TBL] [Abstract][Full Text] [Related]
11. Biochemical behavior of Trypanosoma cruzi strains isolated from mice submitted to specific chemotherapy.
Marretto JP; Andrade SG
Rev Soc Bras Med Trop; 1994; 27(4):209-15. PubMed ID: 7855362
[TBL] [Abstract][Full Text] [Related]
12. Comparative studies of drug susceptibility of five strains of Trypanosoma cruzi in vivo and in vitro.
Neal RA; van Bueren J
Trans R Soc Trop Med Hyg; 1988; 82(5):709-14. PubMed ID: 3075357
[TBL] [Abstract][Full Text] [Related]
13. Lectin receptors distribution in the surface membrane of Trypanosoma cruzi blood forms collected from mice submitted to specific treatment.
Fontes G; Romanha AJ; Pereira ME; Brener Z
Mem Inst Oswaldo Cruz; 1991; 86(3):297-9. PubMed ID: 1842420
[TBL] [Abstract][Full Text] [Related]
14. [Effects of nifurtimox, benznidazole, and beta-lapachone on the metabolism of DNA, RNA and proteins in Trypanosoma cruzi].
Goijman SG; Stoppani AO
Rev Argent Microbiol; 1983; 15(4):193-204. PubMed ID: 6086046
[TBL] [Abstract][Full Text] [Related]
15. Molecular and biological characterization of a highly pathogenic Trypanosoma cruzi strain isolated from a patient with congenital infection.
Gulin JEN; Bisio M; Rocco DM; Altcheh J; Solana ME; García-Bournissen F
Exp Parasitol; 2018 Mar; 186():50-58. PubMed ID: 29448038
[TBL] [Abstract][Full Text] [Related]
16. [Mechanism of the trypanocidal action of nifurtimox and other nitro-derivatives on Trypanosoma cruzi].
Docampo R; Stoppani AO
Medicina (B Aires); 1980; 40 Suppl 1():10-6. PubMed ID: 6779074
[No Abstract] [Full Text] [Related]
17. Molecular characterization of susceptible and naturally resistant strains of Trypanosoma cruzi to benznidazole and nifurtimox.
Murta SM; Gazzinelli RT; Brener Z; Romanha AJ
Mol Biochem Parasitol; 1998 Jun; 93(2):203-14. PubMed ID: 9662705
[TBL] [Abstract][Full Text] [Related]
18. In vitro susceptibility to benznidazole, nifurtimox and posaconazole of Trypanosoma cruzi isolates from Paraguay.
Acosta N; Yaluff G; López E; Bobadilla C; Ramírez A; Fernández I; Escobar P
Biomedica; 2020 Dec; 40(4):749-763. PubMed ID: 33275352
[TBL] [Abstract][Full Text] [Related]
19. Investigating the structure-activity relationships of N'-[(5-nitrofuran-2-yl) methylene] substituted hydrazides against Trypanosoma cruzi to design novel active compounds.
Palace-Berl F; Pasqualoto KFM; Zingales B; Moraes CB; Bury M; Franco CH; da Silva Neto AL; Murayama JS; Nunes SL; Silva MN; Tavares LC
Eur J Med Chem; 2018 Jan; 144():29-40. PubMed ID: 29247858
[TBL] [Abstract][Full Text] [Related]
20. Trypanosoma cruzi: a pharmacological comparison of some Bolivian isoenzymic strains.
Barnabe C; Tibayrenc M; Dujardin JP
Ann Soc Belg Med Trop; 1983 Dec; 63(4):319-24. PubMed ID: 6198978
[No Abstract] [Full Text] [Related]
[Next] [New Search]
